Granite Point Ventures LLC

Granite Point Ventures LLC

Developing innovative strategies.
Achieving growth.

Strategy and product development for life sciences molecular diagnostics and nucleic acid therapeutics.

Start a conversation What we do
Two-state melt curves for three duplexes of equal Tm but differing van't Hoff enthalpy; dashed rays are the tangents at Tm, whose slope gives the van't Hoff enthalpy. Tm 72 °C θ = 0.5 ΔH°vH kcal·mol-1 170 130 90 TEMPERATURE °C FRACTION DUPLEX

The problem

Good products still fail

Developing an innovative product isn't easy. Even acclaimed companies with talent and money can encounter big problems. Having run into a few existential threats ourselves, we know how to overcome them. And how to get an idea to market.

Services

What you can engage us for

Four deliverables, scoped individually or as a single programme of work.

Market sizing

TAM, SAM and the competitive landscape — segment arithmetic that survives a board's questions.

Due diligence & valuation

Technical and commercial diligence for investors, acquirers and boards, and defensible numbers for a raise, a licence or an exit.

Pricing

What the market will bear, and the structure that captures it.

Positioning

The category story — hardest, and most valuable, when the category is new.

Approach

Fixed-price deliverables, on tight deadlines, with constrained resources.

  1. 01

    Scope

    We agree the question, the deliverable and the date before any money moves.

  2. 02

    Fixed price

    The engagement is priced as a deliverable, not as an open meter.

  3. 03

    Deliver

    You get the artefact you can act on — the model, the matrix, the memo — on the agreed date.

Work

Defining a new product category

For a recent engagement, a life sciences company requested market sizing, due diligence, benchmarking, competitive matrix, pricing, valuation, and positioning for an invention that defined a new product category.

Good listener. Trustworthy.
Honest. Follows through. Relentless.

These are a few of the things that molecular diagnostics and nucleic acid therapeutics companies mention when asked, why Granite Point?

Team

Formed in 2015

Granite Point Ventures was formed in 2015 by a group of executives from the molecular diagnostics and life sciences industries. Careers span advanced technical degrees from respected institutions, the leading of focused teams, and progression to leadership of global business and product units.

Along the way, we encountered our share of challenges. These experiences created in each of us a unique tool kit on how to approach people, business, and technical matters. Moreover, we learned how to get to the heart of a problem, how to define objective goals, and how to construct action plans that realize fixed-price deliverables on tight deadline and with constrained resources.

Raymond Peterson

Raymond Peterson, PhD

Partner · Bioinformatics

A graduate of the Wharton School and a PhD in bioinformatics. Start-up and early stage experience in self-funded and venture-backed companies. Able to translate complex technical matters into business cases for general audience.

Joshua Levin

Joshua Levin, PhD

Partner · Regulatory Affairs

Quality and regulatory leader with two decades experience in medical device/IVD ISO 13485:2016 / FDA quality system implementation, risk management per ISO 14971, audits, regulatory compliance and regulatory submissions.

Ines LeBow

Ines LeBow, MA

Partner · Fund Raising

25 years of hands-on experience helping startups secure funding to launch, grow and successfully exit. A veteran of 11 M&A deals and IPO due diligence, she consults with next stage growth companies to scale-up operations.

Contact

Let's talk

Tell us the decision you're trying to make and the date you need it by. If it isn't work we're right for, we'll say so.

info@granitepv.com Replies within two business days.

Granite Point Ventures LLC · College Park, MD